日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer

抗体-药物偶联物 Sacituzumab Govitecan 为乳腺癌患者提供 TOP1/PARP 抑制剂序贯治疗策略

期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-24-0428
Aditya Bardia #, Sheng Sun #, Nayana Thimmiah #, James T Coates, Bogang Wu, Rachel O Abelman, Laura Spring, Beverly Moy, Phoebe Ryan, Mark N Melkonyan, Ann Partridge, Dejan Juric, Jeffrey Peppercorn, Heather Parsons, Seth A Wander, Victoria Attaya, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerl
肿瘤
乳腺癌
发表日期：2024
文献求助 收藏

Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer

乳腺手术和辅助治疗完成情况及及时性方面的差距：一项针对海地非转移性乳腺癌患者的回顾性队列研究

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-022-06582-8
Fadelu, Temidayo A; Erfani, Parsa; Lormil, Joarly; Damuse, Ruth; Pierre, Viergela; Slater, Sarah; Triedman, Scott A; Shulman, Lawrence N; Rebbeck, Timothy R
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Patient Characteristics and Outcomes of Nonmetastatic Breast Cancer in Haiti: Results from a Retrospective Cohort

海地非转移性乳腺癌患者的特征和预后：一项回顾性队列研究的结果

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2019-0951
Fadelu, Temidayo; Damuse, Ruth; Lormil, Joarly; Pecan, Elizabeth; Dubuisson, Cyrille; Pierre, Viergela; Rebbeck, Timothy; Shulman, Lawrence N
肿瘤
肿瘤免疫
乳腺癌
发表日期：2020
文献求助 收藏

Body Mass Index, Chemotherapy-Related Weight Changes, and Disease-Free Survival in Haitian Women With Nonmetastatic Breast Cancer

海地非转移性乳腺癌女性的体重指数、化疗相关体重变化和无病生存期

期刊:JCO Global Oncology
影响因子:3
doi:10.1200/GO.20.00307
Fadelu, Temidayo; Damuse, Ruth; Lormil, Joarly; Pecan, Elizabeth; Greenberg, Lauren; Dubuisson, Cyrille; Pierre, Viergela; Triedman, Scott A; Shulman, Lawrence N; Rebbeck, Timothy R
肿瘤免疫
肿瘤
乳腺癌
发表日期：2020
文献求助 收藏